Hong Kong has one of the highest rates of type 2 diabetes of any developed population in the world, and the reasons go well beyond diet and exercise. According to research published in the Journal of Diabetes Investigation, age- and sex-adjusted incidence rates in Hong Kong Chinese reach between 949 and 1,099 per 100,000 person-years. In the UK and Sweden, comparable figures sit at 370 to 398. That is roughly two to three times the rate, and it cannot be explained by weight alone.
The biology underlying this gap matters. East Asian populations, including Hong Kong Chinese, tend to develop insulin resistance and beta-cell dysfunction at lower body weights than European populations. Visceral fat, the fat that accumulates around internal organs rather than under the skin, plays a significant role even when overall body mass index appears unremarkable. You can be in the normal weight range and still carry the metabolic profile that raises risk substantially.
Understanding this shapes everything about how to read your own risk, what early signs are worth taking seriously, and what the current evidence says about managing or preventing the condition.
What Insulin Resistance Actually Means
Insulin is the hormone your pancreas produces to move glucose from the bloodstream into your cells, where it is used for energy. When your cells stop responding to insulin efficiently, your pancreas compensates by producing more. For a time, blood sugar stays within range, but the system is under strain. This state of reduced cellular sensitivity is insulin resistance, and it typically precedes a type 2 diabetes diagnosis by years, sometimes by more than a decade.
The problem is that insulin resistance is largely silent. There are no obvious symptoms in the early stages, and many people first encounter the term when a routine blood test shows elevated fasting glucose or a raised HbA1c. By that point, some degree of beta-cell fatigue has often already set in. The pancreas has been overworking, and its capacity to compensate starts to decline. This is why the early stages of the process, sometimes labelled prediabetes, are clinically important even though they produce no symptoms you would notice.
Risk Factors Specific to Hong Kong
Family history carries real weight here. If a parent or sibling has type 2 diabetes, your own risk is meaningfully elevated, partly through shared genetic susceptibility and partly through shared household behaviours around food and activity. Age is also a factor, with risk rising from the mid-forties onwards, though cases in younger adults are increasingly common.
Beyond genetics, the structure of daily life in Hong Kong creates its own pressures. Long working hours, high stress, and meal patterns built around convenience and dining out make consistent dietary habits difficult to maintain. Sleep deprivation, which is common in Hong Kong's working population, disrupts glucose metabolism independently of diet. Physical inactivity compounds the effect of visceral fat accumulation, and the problem is not just about whether you exercise but how much time is spent sitting, which affects insulin sensitivity even in people who do work out regularly.
Gestational diabetes during a previous pregnancy is a separate and often underappreciated risk factor. Women who develop it have a substantially higher chance of developing type 2 diabetes later in life, and routine follow-up after delivery is important for that reason.
Early Signs Worth Paying Attention To
Because insulin resistance can progress quietly, the signs that do appear are easy to rationalise away. Persistent fatigue, particularly after meals, is one. When cells cannot use glucose efficiently, energy levels suffer, and post-meal drowsiness that feels disproportionate is sometimes a reflection of blood sugar instability rather than simply overeating.
Increased thirst and more frequent urination are classic symptoms of elevated blood glucose. When blood sugar rises, the kidneys work harder to filter it, drawing water from the body in the process. Slow wound healing, frequent infections, and blurred vision can all follow from sustained elevated glucose, which impairs circulation and immune response over time. Darkened, velvety patches of skin around the neck or armpits, known as acanthosis nigricans, can be a visible marker of insulin resistance and are worth mentioning to a doctor if you notice them.
None of these symptoms alone confirms a diagnosis, but any combination of them, particularly alongside known risk factors, is a reasonable prompt to have your blood glucose and HbA1c checked.
The Burden of Inadequate Blood Sugar Control
Managing type 2 diabetes is not only about how you feel day to day. The downstream consequences of poorly controlled blood sugar accumulate over years and drive the serious complications associated with the condition: cardiovascular disease, kidney damage, nerve damage, and vision loss.
The scale of this in Hong Kong is striking. A population-based modelling study drawing on data from 526,672 individuals with type 2 diabetes in Hong Kong in 2021 found that 84.9% had not achieved optimal combined control of glycated haemoglobin, blood pressure, and LDL-cholesterol. The same modelling estimated that improving combined risk factor control would yield 17,605 additional quality-adjusted life years and healthcare cost savings of US$106.7 million over ten years, with glycaemic control alone accounting for the greatest share of both.
Those figures point to a large gap between what is achievable and what is currently being achieved, even within a population that generally has good access to healthcare. The gap is not primarily about medication; it reflects how difficult sustained lifestyle change and consistent engagement with care are for people managing busy lives alongside a long-term condition.
Glucose Monitoring and What It Can Tell You
Blood glucose monitoring has evolved well beyond the finger-prick test. Continuous glucose monitors and flash glucose monitoring devices track glucose levels throughout the day and night, providing a picture of how your blood sugar responds to meals, activity, sleep, and stress rather than just a single fasting snapshot.
A scoping review of 12 studies across 1,144 participants in eight countries, published in February 2025, found that these devices are increasingly being considered not just for people already diagnosed but for those at elevated risk of developing type 2 diabetes. Most of the studies reviewed used flash glucose monitoring focused on behavioural outcomes, including diet and physical activity, suggesting that real-time data can influence the daily choices that affect glucose control. Seeing the numbers move in response to a particular meal or a walk after eating tends to be more motivating than abstract advice.
Whether a monitoring device is appropriate for your situation is something to discuss with a doctor or diabetes nurse, as the clinical indications and reimbursement landscape vary. But as a category of tool, these devices are playing a growing role in both management and prevention.
Treatment Options: Where Metformin Fits
If blood glucose is elevated beyond what lifestyle change can address, medication is typically part of the picture. Metformin has been a cornerstone of type 2 diabetes management for decades. As a 2024 review in Diabetes, Obesity and Metabolism notes, it has more than 60 years of clinical use behind it, making it one of the most studied glucose-lowering drugs available. It works primarily by reducing glucose production in the liver and improving insulin sensitivity in peripheral tissues.
The treatment landscape has changed, though. Newer drug classes, including SGLT-2 inhibitors and GLP-1 receptor agonists, have demonstrated cardiovascular and kidney-protective effects that go beyond blood sugar control. The same review notes that the evidence for these benefits was largely gathered from patients who were already receiving established treatment, meaning the newer agents often sit alongside rather than simply replace existing therapy. The American Diabetes Association's 2024 Standards of Care reflect this complexity, emphasising evidence-based, individualised approaches to management, with prevention of cardiovascular and kidney complications as a core goal alongside glycaemic targets.
Which combination of treatments is appropriate depends on individual circumstances: cardiovascular risk profile, kidney function, weight, tolerance, and a range of other factors. This is a conversation that belongs between you and whoever is managing your diabetes care.
Diabetes Prevention: What the Evidence Supports
If you have been told your blood sugar is in the prediabetes range, that is not a fixed diagnosis. The progression to type 2 diabetes is not inevitable, and the period before formal diagnosis is when lifestyle changes carry the most leverage.
The evidence base for structured lifestyle intervention is substantial. Sustained weight reduction in the range of 5 to 7% of body weight, achieved through dietary change and regular physical activity, has been shown in multiple trials to reduce the rate of progression from prediabetes to type 2 diabetes. The ADA's 2024 standards also recognise a role for metformin in individuals at high risk who do not achieve sufficient risk reduction through lifestyle change alone, particularly in those with a history of gestational diabetes or who are at the higher end of the prediabetes range.
For people who already have a diagnosis, the same principles apply to complications prevention. Cardiovascular risk management, blood pressure control, and kidney health monitoring are all part of a comprehensive approach that extends beyond glucose control alone. Engaging with a healthcare team that coordinates across these areas makes a measurable difference to long-term outcomes, as the Hong Kong modelling data makes clear.
Finding the Right Support in Hong Kong
Type 2 diabetes is managed across a range of settings in Hong Kong: public hospital outpatient clinics, private general practitioners, specialist endocrinologists, and diabetes nurse educators. What matters is consistency of engagement and, increasingly, the ability to access a team that can address the cardiovascular, renal, and metabolic dimensions of the condition together rather than in isolation.
If you are in the early stages of understanding your risk, a GP with an interest in metabolic health is a reasonable starting point. If you already have a diagnosis and want specialist input on glucose management, medication options, or monitoring technology, an endocrinologist or diabetologist offers a deeper level of expertise. You can search by specialisation and location to find and compare practitioners on Healwith.
